Search

Zai Lab Ltd ADR

Suletud

SektorTervishoid

24.32 -4.52

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

24.02

Max

24.49

Põhinäitajad

By Trading Economics

Sissetulek

191K

-51M

Müük

6.7M

106M

Aktsiakasum

-0.46

Kasumimarginaal

-47.808

Töötajad

1,784

EBITDA

-2.1M

-46M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+61.67% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

5. nov 2026

Turustatistika

By TradingEconomics

Turukapital

831M

2.9B

Eelmine avamishind

28.84

Eelmine sulgemishind

24.32

Uudiste sentiment

By Acuity

50%

50%

81 / 340 Pingereas Healthcare

Zai Lab Ltd ADR Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

3. okt 2026, 00:01 UTC

News

Intellia Therapeutics awarded inducement grants for 44.45k shares to new employees, with shares trading modestly lower in after-market hours.

3. okt 2026, 00:01 UTC

News
Social Media

ImmunityBio Inc closed the week at its highest level in over five years, with anticipation building for its upcoming Q3 report and potential BCG data.

3. okt 2026, 00:01 UTC

News
Social Media

GameStop shares rise in after-hours trading following CEO Ryan Cohen's $17 million purchase of 700k Class A shares, increasing his stake to nearly 9%.

3. okt 2026, 00:01 UTC

News
Social Media

The U.S. Department of Energy plans to extend $4 billion in loans to Vistra Corp for upgrades at three nuclear reactors, boosting after-market shares.

3. okt 2026, 00:00 UTC

News

McDonald's Corp shares are trading higher in after-market hours following the presentation of its NEXT strategy to enhance revenue through its customer base.

3. okt 2026, 00:00 UTC

News

American Airlines Group Inc is seeing a modest increase in after-market hours following its announcement allowing AAdvantage members to combine cash and miles for bookings.

2. okt 2026, 23:35 UTC

News

Honeywell International Inc. is seeing slight gains in after-market trading, following commentary from its CTO on AI implementation challenges in industrial settings.

2. okt 2026, 23:35 UTC

News

Deere & Co. is trading higher in after-market hours, driven by growth in construction and small equipment units despite weaker results in agriculture.

2. okt 2026, 23:25 UTC

News

Kohl's Corp has a market valuation of approximately $2.1 billion, with after-market trading showing modest gains near the upper end of its one-month range.

2. okt 2026, 23:11 UTC

News

Intellia Therapeutics Inc granted inducement awards of 44.45k restricted stock units to new employees, with the stock trading lower in after-market hours.

2. okt 2026, 23:10 UTC

News

McDonald's Corp is seeing a slight increase in after-market trading, supported by its McDonald's NEXT initiative to enhance revenue through customer engagement.

2. okt 2026, 23:05 UTC

News

Boeing's stock rose slightly in after-market trading after the FAA confirmed a software glitch in the 737 MAX does not pose an in-flight safety issue.

2. okt 2026, 23:05 UTC

News

American Airlines Group Inc. experienced routine after-market trading, remaining roughly flat since Friday's close amid a recent downward trend over the last three sessions.

2. okt 2026, 23:05 UTC

News

Verra Mobility Corp is higher in after-market trading, rebounding from recent declines amid investor concerns over the upcoming leadership transition effective November 1, 2026.

2. okt 2026, 23:01 UTC

Social Media
News

In after-market hours, Synaptics shares are trading lower as Onsemi revises its acquisition proposal to $123 per share in cash, valuing the deal at $5.7 billion.

2. okt 2026, 23:01 UTC

News
Social Media

GameStop shares rise in after-hours trading following CEO Ryan Cohen's purchase of 700k Class A shares for approximately $17 million, signaling confidence in the company's prospects.

2. okt 2026, 23:01 UTC

Social Media
News

Vistra Corp shares are higher in after-market trading as the U.S. Department of Energy plans to extend $4 billion in loans for nuclear reactor upgrades.

2. okt 2026, 21:03 UTC

Macro Event
News

USD/THB exchange rate is declining modestly, influenced by disappointing U.S. employment data, including a lower-than-expected jobs added figure of 46k in September.

2. okt 2026, 21:01 UTC

News

Xenon Pharmaceuticals Inc announced equity inducement grants to new employees, with after-market trading showing a slight gain since Friday's close.

2. okt 2026, 20:12 UTC

News

Endava PLC's stock is declining in after-market trading amid increased scrutiny and a class action lawsuit following CFO Mark Thurston's administrative leave due to accounting concerns.

2. okt 2026, 20:09 UTC

News

Cloudflare Inc shares are declining, pulling back after earlier strength, amid broader market weakness, following a modest drop since Thursday's close.

2. okt 2026, 20:09 UTC

News
Social Media

Rocket Lab shares are advancing following ARK Invest's $16.4 million purchase of 233.48k shares, adding to over $44 million in recent investments.

2. okt 2026, 20:09 UTC

News
Social Media

Oracle Corp shares are advancing following a $3.48 million insider purchase by Board Member Stephen Rusckowski and a 29.61% revenue growth rate.

2. okt 2026, 20:09 UTC

Macro Event
News
Social Media

MARA Holdings Inc. sees bullish option activity with call volume at 68.48k contracts, three times the expected amount, as shares move higher.

2. okt 2026, 20:09 UTC

Correlated Moves
News
Macro Event

Ford Motor Co trades lower since Thursday's close.

2. okt 2026, 20:09 UTC

Correlated Moves
News
Macro Event
Social Media

Dell Technologies partners with Jera for a $15 billion data center near Tokyo, contributing to Japan's $140 billion investment in data center development.

2. okt 2026, 20:09 UTC

News
Macro Event

Marvell Technology Inc shares are up as positive sentiment builds ahead of its October 6 Investor Day, with calls outpacing puts in options trading.

2. okt 2026, 20:09 UTC

Macro Event
News

Booking Holdings Inc. shares fell sharply as mixed macroeconomic indicators, including disappointing U.S. employment data, weighed on market sentiment.

2. okt 2026, 20:09 UTC

News

Scotiabank upgraded Americold Realty Trust to Sector Outperform, maintaining a $16 price target, contributing to gains in today's trading session.

2. okt 2026, 20:09 UTC

News
Social Media

Shares of AppLovin fell sharply after a court denied its request for a restraining order against Unity's Ad Quality SDK, indicating competitive pressure.

Võrdlus sarnastega

Hinnamuutus

Zai Lab Ltd ADR Prognoos

Hinnasiht

By TipRanks

61.67% tõus

12 kuu keskmine prognoos

Keskmine 39.333 USD  61.67%

Kõrge 45 USD

Madal 36 USD

Põhineb 3 Wall Streeti analüütiku instrumendi Zai Lab Ltd ADR 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

3 ratings

3

Osta

0

Hoia

0

Müü

Sentiment

By Acuity

81 / 340 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.